Company Filing History:
Years Active: 2017
Title: Iwona M Maciagiewicz: Innovator in Nucleic Acid Compounds
Introduction
Iwona M Maciagiewicz is a prominent inventor based in Oak Park, IL (US). She has made significant contributions to the field of nucleic acid compounds, particularly through her innovative patent work. Her research focuses on the synthesis and applications of conformationally restricted nucleomonomers, which have important implications in therapeutic modalities.
Latest Patents
Iwona holds a patent titled "Synthesis and uses of nucleic acid compounds with conformationally restricted monomers." This patent details processes for synthesizing conformationally restricted nucleomonomers (CRN) through ozonolysis or oxidation of a 2'-vinyl substituted nucleoside precursor. The CRN nucleomonomers can be produced in high yields and on a multi-gram scale. These nucleomonomers are essential for preparing nucleic acid compounds that can be utilized in various regulatory classes, such as antisense RNA, which is useful for treating or preventing diseases by regulating gene expression.
Career Highlights
Iwona is currently associated with Marina Biotech, Inc., where she continues her research and development in the field of nucleic acids. Her work has garnered attention for its potential applications in medical therapies and gene regulation.
Collaborations
Iwona collaborates with notable colleagues, including Tracy Matray and Michael E Houston, Jr. These partnerships enhance her research capabilities and contribute to the advancement of nucleic acid technologies.
Conclusion
Iwona M Maciagiewicz is a trailblazer in the field of nucleic acid compounds, with a patent that showcases her innovative approach to synthesis and application. Her contributions are paving the way for new therapeutic strategies in medicine.